Exploratory data show inavolisib benefits persist regardless of hyperglycemia in PIK3CA-mutated breast cancer, with ...

Patients younger than 40 years had the highest increase in overall incidence (APC 3.1%, 95% CI 2.2-4.0), which was driven by ...

The factor XIa inhibitor reduced the rate of disabling/fatal strokes versus placebo, with a consistent net clinical benefit.

From ancient philosophy to modern neuroscience, exploring why pain need not be suffered in silence.

Endovascular thrombectomy is indicated for acute ischemic stroke due to a large vessel occlusion in the anterior circulation ...

The rise of Vijay from matinee idol to Chief Minister of Tamil Nadu is not merely a political victory. It is a civilisational ...

Breaking down the 90 players on the 49ers’ offseason roster in 90 posts (over 90 or so days). Today is DT CJ West ...

Giredestrant plus everolimus does not increase treatment burden in advanced breast cancer, new safety and patient-reported outcome data from the evERA BC trial show.

An RCT is planned in patients with conduction disturbances not covered by current pacing indications, says Josep Rodés-Cabau.

Myopia progressed more slowly across 2 years in children wearing Acuvue Abiliti 1-Day daily disposable contact lenses, ...

Phase 2 monotherapy trial of FG-3246, a potential first-in-class antibody drug conjugate (ADC) targeting CD46, in metastatic castration-resistant ...

One of the most successful coaches of the last decade shares how he came up with his core values — and how he actually ...